Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00763984 · ClinicalTrials.gov registry record · Phase 3

Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women

A Phase 3 study of Urinary Incontinence, sponsored by University of Michigan.

Completed
Registry status
Phase 3
Development phase
432
Enrollment target
3
Study locations

NCT00763984: Completed Phase 3 study of Urinary Incontinence, sponsored by University of Michigan.

NCT00763984 is a Phase 3 study of Urinary Incontinence that has completed, run by University of Michigan. The registered enrollment target is 432 participants, above the 253-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (71% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00763984, a Phase 3 study of Urinary Incontinence, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 3
Development phase
432 participants
Enrollment target
3
Study locations

Study Summary

The primary goal of this project is to determine the efficacy of an antenatal Bladder Health class to prevent UI in a diverse sample of African American, Caucasian, and Hispanic childbearing women. The determination of efficacy will be made at 12-months post index birth, a time point that is a traditional benchmark of recovery from childbirth, using UI incidence/severity as the primary outcome.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Bladder Health class

Study Locations (3)

Michigan

  • University of Michigan Health System - Ann Arbor
  • Jackson Center for Family Health - Jackson
  • La Clinica de la Santa Teresa - Pontiac

Trial Details

FieldValue
Enrollment Target 432 participants
Start Date 2007-10
Est. Completion 2013-12
Phase Phase 3
University of Michigan

1,327 total trials

What the finished NCT00763984 record still lists

NCT00763984 is an interventional study that assigns participants to a tested intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap, above the 253-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (71% higher).

The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00763984 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00763984 about?

NCT00763984 is a clinical study titled "Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women". The primary goal of this project is to determine the efficacy of an antenatal Bladder Health class to prevent UI in a diverse sample of African American, Caucasian, and Hispanic childbearing women. The determination of efficacy will be made at 12-months post index birth, a time point that is a tradi...

What is the current status of trial NCT00763984?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 432 participants. The study started on 2007-10. Estimated completion is 2013-12.

What conditions does trial NCT00763984 study?

This clinical trial studies the following conditions: Urinary Incontinence.

What interventions are being tested in trial NCT00763984?

The interventions under investigation include: Usual Care (BEHAVIORAL), Bladder Health class (BEHAVIORAL).

Who is sponsoring clinical trial NCT00763984?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00763984 being conducted?

This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00763984's enrollment target sits among peer trials

432 8th of 48 higher than 41 of 48 other Urinary Incontinence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05271240 · 432 participants · Phase 3

    Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

  • NCT05365815 · 432 participants · NA

    Melanated Group Midwifery Care (MGMC)

  • NCT05499507 · 432 participants · NA

    The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

  • NCT05806164 · 432 participants · Phase 4

    Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00763984, the US trial registry maintained by the National Library of Medicine. NCT00763984 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.